BUZZ-TG Therapeutics jumps after preliminary 2025 sales exceed forecast

Reuters01-14

BUZZ-TG <a href="https://laohu8.com/S/LENZ">Therapeutics</a> jumps after preliminary 2025 sales exceed forecast

** Shares of drugmaker TG Therapeutics TGTX.O up 7% at $29.88 in extended trading

** Preliminary full-year 2025 net sales of $616 million, compared to previous projection of $600 million

** Expects 2026 net sales in the range of $875 million to $900 million, compared to estimates of $895.6 million — data compiled by LSEG

** Co expects its new IV infusion schedule for multiple sclerosis drug Briumvi to boost revenue in the near term, if approved, says CEO Michael Weiss

** Stock fell marginally in 2025

(Reporting by Koyena Das in Bengaluru)

((koyena.das@thomsonreuters.com))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2603656065?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-01-14 07:42","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2603656065","market":"us","top_or_hot":-1,"title":"BUZZ-TG Therapeutics jumps after preliminary 2025 sales exceed forecast","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BUZZ-TG <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> jumps after preliminary 2025 sales exceed forecast</title></head><body><p>** Shares of drugmaker TG Therapeutics <span>TGTX.O</span> up 7% at $29.88 in extended trading</p><p>** Preliminary full-year 2025 net sales of $616 million, compared to previous projection of $600 million</p><p>** Expects 2026 net sales in the range of $875 million to $900 million, compared to estimates of $895.6 million — data compiled by LSEG</p><p>** Co expects its new IV infusion schedule for multiple sclerosis drug Briumvi to boost revenue in the near term, if approved, says CEO Michael Weiss</p><p>** Stock fell marginally in 2025</p><p>(Reporting by Koyena Das in Bengaluru)</p><p>((koyena.das@thomsonreuters.com))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BUZZ-TG Therapeutics jumps after preliminary 2025 sales exceed forecast</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBUZZ-TG Therapeutics jumps after preliminary 2025 sales exceed forecast\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2026-01-14 07:42</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BUZZ-TG <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> jumps after preliminary 2025 sales exceed forecast</title></head><body><p>** Shares of drugmaker TG Therapeutics <span>TGTX.O</span> up 7% at $29.88 in extended trading</p><p>** Preliminary full-year 2025 net sales of $616 million, compared to previous projection of $600 million</p><p>** Expects 2026 net sales in the range of $875 million to $900 million, compared to estimates of $895.6 million — data compiled by LSEG</p><p>** Co expects its new IV infusion schedule for multiple sclerosis drug Briumvi to boost revenue in the near term, if approved, says CEO Michael Weiss</p><p>** Stock fell marginally in 2025</p><p>(Reporting by Koyena Das in Bengaluru)</p><p>((koyena.das@thomsonreuters.com))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"TGTX","symbol_name":"TG Therapeutics Inc.","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260113:nL6N3YE1L4:1","article_id":"2603656065","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2603656065","pubTimestamp":1768347738,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BUZZ-TG Therapeutics jumps after preliminary 2025 sales exceed forecast** Shares of drugmaker TG Therapeutics TGTX.O up 7% at $29.88 in extended trading** Preliminary full-year 2025 net sales of $616 million, compared to previous projection of $600 million** Expects 2026 net sales in the range of $875 million to $900 million, compared to estimates of $895.6 million — data compiled by LSEG** Co expects its new IV infusion schedule for multiple sclerosis drug Briumvi to boost revenue in the near term, if approved, says CEO Michael Weiss** Stock fell marginally in 2025","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"TGTX":"TG Therapeutics Inc.","BK4585":"ETF&股票定投概念","BK4588":"碎股","BK4139":"生物科技"},"translate_title":"Buzz-TG Therapeutics 2025年初步销售额超出预期后股价上涨","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"TGTX":0.9},"content_text":"BUZZ-TG Therapeutics jumps after preliminary 2025 sales exceed forecast** Shares of drugmaker TG Therapeutics TGTX.O up 7% at $29.88 in extended trading** Preliminary full-year 2025 net sales of $616 million, compared to previous projection of $600 million** Expects 2026 net sales in the range of $875 million to $900 million, compared to estimates of $895.6 million — data compiled by LSEG** Co expects its new IV infusion schedule for multiple sclerosis drug Briumvi to boost revenue in the near term, if approved, says CEO Michael Weiss** Stock fell marginally in 2025(Reporting by Koyena Das in Bengaluru)((koyena.das@thomsonreuters.com))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"dataReport","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2603656065","isCrawlerRequest":true}